IDA/ Hemophilia/ Thalassemia/ G6PD deficiency/ neuroblastoma Flashcards
G6PD deficiency is a disease involving enzymes of the hexose monophosphate pathway.
true
It has 3 clinical syndromes episodic hemolytic anemia, autoimmune hemolytic anemia and chronic non-spherocytic hemolytic anemia.
false
The most common manifestations are pallor and episodic acute hemolytic anemia.
false
The normal enzyme found in most populations is designated G6PD B+
true
For episodic or induced hemolytic anemia, reduced GSH provides protection against oxidant threats from certain drugs and infections that would otherwise cause precipitation of hemoglobin (Heinz bodies) or damage the RBC membrane.
true
Synthesis of RBC G6PD is determined by a gene on the X chromosome.
true
Heterozygous females have intermediate enzymatic activity and have 2 populations of RBC: one is normal and the other is deficient in G6PD activity.
true
Heterozygous females have many susceptible cells, hence, they have evident clinical hemolysis after exposure to oxidant drugs.
false
Episodic hemolytic anemia occurs more frequently in males than in females.
true
Most individuals with G6PD deficiency are asymptomatic with no clinical manifestations of illness unless triggered by infection, drugs or ingestion of fava beans.
true
The degree of hemolysis varies with the inciting agent, amount ingested and severity of the enzyme deficiency.
true
G6PD deficiency cannot produce hemolysis in the neonatal period.
false
Heinz bodies are visible on Wright stained blood film and seen within 7 days.
false
The diagnosis of G6PD by direct measurement is that enzyme activity in affected persons is ≤ 10% of normal.
true
After a hemolytic episode reticulocytes and young RBC predominant so testing can be done now.
false
Diagnosis can be suspected when G6PD activity is within the low normal range in the presence of a high reticulocyte count.
true
G6PD deficiency should not be considered in any neonatal patients with hyperbilirubinemia and borderline low G6PD activity.
false
Prevention of hemolysis constitutes the most important therapeutic measure.
true
The usual doses of aspirin and trimethoprim-sulfamethoxazole cause clinically relevant hemolysis in the A - variety.
false
If severe hemolysis has occurred, supportive therapy may require blood transfusion although recovery is the rule when the oxidant agent is discontinued.
true
Neuroblastoma is the most common extracranial solid tumor in children and the most commonly diagnosed malignancy in infants.
true
Neuroblastoma tumors for a spectrum from tumors in the primarily undifferentiated small round cells (neuroblastoma) to tumors consisting of mature and maturing Schwannian stroma.
true
The tumors may resemble other small round blue cell tumors such as rhabdomyosarcoma, Ewing’s Sarcoma and Osteosarcoma.
false
Genetic characteristics of neuroblastoma tumors that are of prognostic importance include amplification of the MYCN (N-myc) protooncogene and tumor cell DNA content or ploidy.
true
Neuroblastoma develops only at one site of sympathetic nervous system tissue.
false
The signs and symptoms of neuroblastoma mimics many other disorders hence early diagnosis.
false
Neuroblastoma originating in the superior cervical ganglion can result in Horner Syndrome.
true
Stage 4s has an incidence of 5% and survival at 5 yrs is <80%.
false
Neuroblastoma can be diagnoses without a primary tumor biopsy if small round blue tumor cells are observed in bone marrow samples.
true
Tumor markers homovanillic acid and vanillylmandelic acid are elevated in the blood of approximately 95% of cases and help to confirm the diagnosis.
false
INSS stage 4s refer to neuroblastoma in children younger than 1 year of age with discrimination to liver, skin and/or bone marrow without bone involvement and with a primary tumor that would otherwise be staged as INSS stage 1 or 2.
true
The usual treatment for children with low risk neuroblastoma is surgery for stage 1 or 2.
true
The treatment for stage 4s with cure rates generally >90% without further therapy.
true
Stage 4s neuroblastoma have an unfavorable prognosis and do not regress spontaneously without therapy.
false
Children with intermediate risk neuroblastoma including children with stage 3 disease and infants with stage 4 disease and favorable characteristics have an excellent prognosis and >90% survival with moderate treatment.
true
Hemophilia A and Hemophilia B are the most common and serious congenital coagulation factor deficiencies and their clinical findings are virtually identical.
true